By GREGORY ZELLER //SEPTEMBER 19, 2019
Mark another impressive victory for LineaRX, this time in a two-front battle against cancer.
The Stony Brook-based biotech with innovation in its DNA (literally) has lent its unique DNA-sequencing technology to two vaccine-candidate tests run by Italian R&D company Takis Biotech, which is hot on the trail of new therapeutic cancer vaccines.
